Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 3 (2006), Issue 1 (January)

1. Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy.
   Am J Ophthalmol, 141(1): 129-134. [Abstract] [Full-text]
2. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals.
   Ophthalmology, 113(1): 23-8. [Abstract] [Full-text]
3. Influence of various central moieties on the hypolipidemic properties of long hydrocarbon chain diols and diacids.
   J Med Chem, 49(1): 334-48. [Abstract] [Full-text]
4. A large family with Charcot-Marie-Tooth Type 1a and Type 2 diabetes mellitus.
   Int J Neurosci, 116(2): 103-14. [Abstract] [Full-text]
5. Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes.
   Am J Physiol Regul Integr Comp Physiol, 290(2): R435-41. [Abstract] [Full-text]
6. Effect of perioperative glycemic control in progression of diabetic retinopathy and maculopathy.
   Arch Ophthalmol, 124(1): 38-45. [Abstract] [Full-text]
7. Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults.
   J Clin Endocrinol Metab, 91(1): 185-91. [Abstract] [Full-text]
8. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.
   J Clin Endocrinol Metab, 91(1): 295-9. [Abstract] [Full-text]
9. Adiponectin is inversely associated with renal function in type 1 diabetic patients.
   J Clin Endocrinol Metab, 91(1): 129-35. [Abstract] [Full-text]
10. Impaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensin-converting enzyme inhibitor therapy.
    J Clin Endocrinol Metab, 91(1): 31-5. [Abstract] [Full-text]
11. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.
    Arch Intern Med, 166(1): 106-11. [Abstract] [Full-text]
12. Physical training reverses the increased activity of the hepatic ketone body synthesis pathway in chronically diabetic rats.
    Am J Physiol Endocrinol Metab, 290(2): E207-12. [Abstract] [Full-text]
13. Renal angiotensin II AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats.
    Am J Physiol Renal Physiol, 290(2): F503-8. [Abstract] [Full-text]
14. Aldosterone increases urine production and decreases apical AQP2 expression in rats with diabetes insipidus.
    Am J Physiol Renal Physiol, 290(2): F438-49. [Abstract] [Full-text]
15. Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats.
    Am J Physiol Endocrinol Metab, 290(2): E243-50. [Abstract] [Full-text]
16. Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once daily.
    J Urol, 175(2): 624-8; discussion 628. [Abstract] [Full-text]
17. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.
    BMJ, 332(7533): 73-8. [Abstract] [Full-text]
18. Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study.
    CMAJ, 174(2): 169-74. [Abstract] [Full-text]
19. Modulation of glucose transporter (GLUT4) by vanadate and Trigonella in alloxan-diabetic rats.
    Life Sci, 78(8): 820-4. [Abstract] [Full-text]
20. Cloricromene effect on the enzyme activities of the tryptophan-nicotinic acid pathway in diabetic/hyperlipidemic rabbits.
    Life Sci, 78(8): 785-94. [Abstract] [Full-text]
21. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
    Clin Exp Immunol, 143(2): 194-202. [Abstract] [Full-text]
22. Review of prevalence and outcome of vascular disease in patients with diabetes mellitus.
    Eur J Vasc Endovasc Surg, 31(2): 143-50. [Abstract] [Full-text]
23. Trends in the presentation and surgical management of the acute diabetic foot.
    Eur J Vasc Endovasc Surg, 31(2): 151-6. [Abstract] [Full-text]
24. Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss.
    Biochem Biophys Res Commun, 340(4): 1091-7. [Abstract] [Full-text]
25. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study.
    J Natl Cancer Inst, 98(2): 135-8. [Abstract] [Full-text]
26. The use of adherence aids by adults with diabetes: a cross-sectional survey.
    BMC Fam Pract, 7: 1. [Abstract] [Full-text]
27. Platelet FcgammaRIIA expression is associated with the alpha2 integrin C807T gene polymorphism in type 2 diabetes.
    Platelets, 17(2): 78-83. [Abstract] [Full-text]
28. Impaired retinal autoregulation in small retinal arterioles before and after focal laser treatment for diabetic maculopathy.
    Br J Ophthalmol, 90(2): 198-201. [Abstract] [Full-text]
29. Platelet inhibition by insulin is absent in type 2 diabetes mellitus.
    Arterioscler Thromb Vasc Biol, 26(2): 417-22. [Abstract] [Full-text]
30. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.
    Arterioscler Thromb Vasc Biol, 26(2): 398-405. [Abstract] [Full-text]
31. The hypothalamus-pituitary-ovary axis and type 1 diabetes mellitus: a mini review.
    Hum Reprod, 21(2): 327-37. [Abstract] [Full-text]
32. Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy.
    Mol Cell Biol, 26(3): 1087-97. [Abstract] [Full-text]
33. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection.
    J Am Acad Dermatol, 54(2): S14-7. [Abstract] [Full-text]
34. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease.
    Arch Intern Med, 166(2): 213-9. [Abstract] [Full-text]
35. Myogenic tone and reactivity of rat ophthalmic artery in acute exposure to high glucose and in a type II diabetic model.
    Invest Ophthalmol Vis Sci, 47(2): 683-92. [Abstract] [Full-text]
36. Complex relationship between blood pressure and mortality in type 2 diabetic patients: a follow-up of the Botnia Study.
    Hypertension, 47(2): 168-73. [Abstract] [Full-text]
37. Type D personality and diabetes predict the onset of depressive symptoms in patients after percutaneous coronary intervention.
    Am Heart J, 151(2): 367.e1-367.e6. [Abstract] [Full-text]
38. Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.
    J Clin Pathol, 59(2): 211-5. [Abstract] [Full-text]
39. Low insulin-like growth factor-II levels predict weight gain in normal weight subjects with type 2 diabetes.
    Am J Med, 119(2): 167.e9-15. [Abstract] [Full-text]
40. Effects of streptozotocin-induced diabetes and insulin on calcium responsiveness of the rat vas deferens.
    Life Sci, 78(10): 1084-90. [Abstract] [Full-text]
41. Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor?
    CMAJ, 174(3): 319-23. [Abstract] [Full-text]
42. Risk of plantar ulceration in diabetic patients with single-leg amputation.
    Clin Biomech (Bristol, Avon), 21(3): 306-13. [Abstract] [Full-text]
43. Living with diabetes: perceptions of Hispanic migrant farmworkers.
    J Community Health Nurs, 23(1): 49-64. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.